Speaker Profile

Ph.D., CSO, Notable Labs

Joe has been working in biotech for nearly 20 years and was previously Executive Director of the University of California Drug Discovery Consortium (UC-DDC). A pharmacologist by training, Joe has spent the majority of his biotechnology industry career focused on building teams and organizations primarily focused on developing small molecule and biologic therapeutics from bench studies through to Phase II clinical trials at companies including BriaCell Therapeutics, OncoCyte and Cell Targeting, where he served in CEO/CTO roles.

Clinical & Research Tools Showcase:
Notable Labs

Notable is a clinical-stage platform therapeutics company designing and delivering predictive precision medicines, a new class of medicines. Notable aims to revolutionize the way in which patients seek and receive treatments that work best for them – patient by patient, and cancer by cancer.

Advancing Predictive Precision Medicine Using Functional Approach
Although genomic- and biomarker-driven precision medicine strategies have improved outcomes for those patients with certain disease characteristics, most cancer patients lack actionable mutations or biomarkers. Predictive precision medicine utilizing a functional, ex vivo approach offers hope for those patients.

 Session Abstract – PMWC 2022 Silicon Valley

Track 7, June 28-30

The PMWC 2022 Emerging Therapeutics Showcase will provide a 15-minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.

- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy